PRECIGEN, INC. — Director's Dealing 2013

Jul 30, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fibrocell Science, Inc. (FCSC)
CIK: 0000357097
Period of Report: 2013-07-26

Reporting Person: KIRK RANDAL J (10% Owner)
Reporting Person: INTREXON CORP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-26	Common Stock	P	1243781	$6.03	Acquired	2561301	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8000000	Indirect

Footnotes

F1: Shares were issued on July 26, 2013 as partial consideration in connection with the First Amendment to the Exclusive Channel Collaboration Agreement dated June 28, 2013 between the issuer and Intrexon Corporation pursuant to a Supplemental Stock Issuance Agreement dated June 28, 2013 between the issuer and Intrexon Corporation.

F2: Shares reflect a one-for-twenty-five reverse stock split effected by the issuer on April 30, 2013.

F3: Randal J. Kirk, directly and through certain affiliates, has voting and dispositive power over a majority of the outstanding capital stock of Intrexon Corporation. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon Corporation. Shares held by Intrexon Corporation may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

F4: Randal J. Kirk controls NRM VII Holdings I, LLC ("NRM VII Holdings"). Shares held by this entity may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.